BSG and primary cutaneous T-cell non-Hodgkin lymphoma: Anti-CD147 antibody and/or anti-CypA antibody suppressed the proliferation of CTCL cell lines, both in vitro and in vivo via downregulation of phosphorylated ERK1/2 and Akt.